NPI: 1346269982 · MCMINNVILLE, OR 97128 · General Acute Care Hospital · NPI assigned 07/18/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 07/18/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 39,922 | $2.12M |
| 2019 | 40,418 | $2.34M |
| 2020 | 31,632 | $1.90M |
| 2021 | 36,637 | $2.23M |
| 2022 | 40,581 | $2.59M |
| 2023 | 37,321 | $3.20M |
| 2024 | 29,911 | $2.91M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 24,814 | 21,349 | $5.27M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 33,876 | 30,323 | $5.04M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,911 | 8,783 | $3.68M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,469 | 9,974 | $456K |
| 80053 | Comprehensive metabolic panel | 33,951 | 28,404 | $323K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12,075 | 10,008 | $312K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 32,046 | 27,259 | $271K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,616 | 3,996 | $238K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,237 | 2,926 | $226K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,388 | 2,218 | $194K |
| 83690 | 8,612 | 7,528 | $170K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,492 | 1,097 | $160K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,843 | 6,082 | $108K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,435 | 2,989 | $73K |
| 71045 | Radiologic examination, chest; single view | 6,773 | 5,716 | $71K |
| 41899 | Unlisted procedure, dentoalveolar structures | 24 | 24 | $56K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,941 | 5,231 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 948 | 827 | $42K |
| 97597 | 891 | 439 | $42K | |
| 81003 | 8,783 | 7,678 | $42K | |
| 11043 | 576 | 230 | $39K | |
| 84484 | 2,446 | 2,030 | $36K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,269 | 4,670 | $36K |
| 84703 | 2,188 | 1,983 | $36K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 718 | 621 | $31K |
| 81001 | 4,008 | 3,450 | $30K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 895 | 289 | $27K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,585 | 893 | $24K |
| 36415 | Collection of venous blood by venipuncture | 9,850 | 7,150 | $20K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 59 | 52 | $19K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 117 | 95 | $18K |
| 85027 | 2,959 | 2,018 | $14K | |
| 70450 | Computed tomography, head or brain; without contrast material | 80 | 61 | $12K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,294 | 1,177 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 793 | 678 | $9K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 13 | 12 | $9K |
| 87430 | 712 | 658 | $8K | |
| 87081 | 541 | 494 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | 845 | 642 | $8K |
| 82803 | 433 | 370 | $7K | |
| 99152 | 336 | 293 | $7K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 40 | 38 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 147 | 135 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 116 | 111 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 117 | 114 | $4K |
| 99153 | Mod sedat endo service >5yrs | 544 | 434 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 824 | 635 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,039 | 956 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 212 | 181 | $3K |
| 86592 | 234 | 213 | $3K | |
| 87070 | 245 | 155 | $2K | |
| 87075 | 228 | 146 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 803 | 729 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 152 | 133 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 54 | 51 | $2K |
| 86850 | 128 | 111 | $2K | |
| 87205 | 274 | 166 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 36 | 32 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 32 | 27 | $1K |
| G0378 | Hospital observation service, per hour | 28 | 24 | $1K |
| 86787 | 62 | 53 | $1K | |
| 86803 | 62 | 55 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 54 | 45 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 12 | 12 | $959.28 |
| 86901 | 129 | 109 | $956.10 | |
| 86900 | 128 | 108 | $944.42 | |
| 83605 | 79 | 64 | $889.59 | |
| 85610 | 292 | 258 | $864.48 | |
| 80061 | Lipid panel | 216 | 141 | $822.70 |
| 87186 | 56 | 30 | $777.93 | |
| 86762 | 49 | 43 | $759.04 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 15 | 13 | $642.60 |
| 87340 | 30 | 28 | $552.38 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 42 | 39 | $538.88 |
| 82728 | 40 | 36 | $509.28 | |
| 84425 | 13 | 12 | $505.40 | |
| 87077 | 88 | 52 | $492.89 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 21 | 15 | $483.78 |
| 84702 | 17 | 12 | $379.30 | |
| 84439 | 17 | 15 | $362.50 | |
| 83970 | 32 | 24 | $343.66 | |
| 82746 | 13 | 12 | $338.80 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 34 | 31 | $298.62 |
| 80048 | Basic metabolic panel (calcium, ionized) | 81 | 68 | $272.95 |
| 80069 | 50 | 41 | $253.88 | |
| 83880 | 13 | 12 | $252.70 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 137 | 129 | $245.28 |
| 87653 | 16 | 12 | $237.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 13 | 12 | $198.65 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 349 | 313 | $184.92 |
| 83735 | 25 | 24 | $155.89 | |
| 83550 | 13 | 12 | $123.20 | |
| 83921 | 13 | 12 | $44.80 | |
| J7050 | Infusion, normal saline solution, 250 cc | 12 | 12 | $22.96 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 53 | 50 | $7.70 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 19 | 12 | $0.00 |
| 97605 | 32 | 12 | $0.00 |